These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 21598346)

  • 1. To excel or to confirm? That is the question.
    Dangas G
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):944. PubMed ID: 21598346
    [No Abstract]   [Full Text] [Related]  

  • 2. Validating the EXCEL hypothesis: a propensity score matched 3-year comparison of percutaneous coronary intervention versus coronary artery bypass graft in left main patients with SYNTAX score ≤32.
    Capodanno D; Caggegi A; Capranzano P; Cincotta G; Miano M; Barrano G; Monaco S; Calvo F; Tamburino C
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):936-43. PubMed ID: 21547994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Each generation improves on the last (in cardiology): Bayesian thinking, the randomized clinical trial, and directed evolution.
    Morrison DA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):1018-9. PubMed ID: 21598353
    [No Abstract]   [Full Text] [Related]  

  • 4. The Gordian knot of revascularization for multivessel coronary artery disease.
    Takagi H; Manabe H; Umemoto T
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):241-2; author reply 242-3. PubMed ID: 21683848
    [No Abstract]   [Full Text] [Related]  

  • 5. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 6. Left main and high-risk PCI: what, exactly, is it high risk for?
    Safian RD
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):952-3. PubMed ID: 21598347
    [No Abstract]   [Full Text] [Related]  

  • 7. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 8. Ten years after: "I'd love to change the world".
    Tommaso CL
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):427. PubMed ID: 19681115
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
    Delhaye C; Sudre A; Lemesle G; Vanesson L; Koussa M; Fayad G; Bauters C; Lablanche JM; Modine T
    Arch Cardiovasc Dis; 2010 Oct; 103(10):502-11. PubMed ID: 21130963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DES in SVGs: safe and at least short-term effective.
    Hillegass WB
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):356-7. PubMed ID: 21328680
    [No Abstract]   [Full Text] [Related]  

  • 11. It's not the dye, but the "die" in dialysis: which coronary revascularization strategy really is best?
    Butman SM
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):949-50. PubMed ID: 21108371
    [No Abstract]   [Full Text] [Related]  

  • 12. Class I indications for coronary artery bypass graft surgery: what is the appropriate therapy for patients with multivessel coronary disease?
    Dean LS
    JACC Cardiovasc Interv; 2009 Jul; 2(7):622-3. PubMed ID: 19628184
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety and efficacy of drug eluting stents compared with bare metal stents for saphenous vein graft interventions: a comprehensive meta-analysis of randomized trials and observational studies comprising 7,994 patients.
    Hakeem A; Helmy T; Munsif S; Bhatti S; Mazraeshahi R; Cilingiroglu M; Effat M; Leesar M; Arif I
    Catheter Cardiovasc Interv; 2011 Feb; 77(3):343-55. PubMed ID: 21328679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: a meta-analysis of randomized and nonrandomized studies.
    Yan TD; Padang R; Poh C; Cao C; Wilson MK; Bannon PG; Vallely MP
    J Thorac Cardiovasc Surg; 2011 May; 141(5):1134-44. PubMed ID: 21167508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A commentary on Diabetic and non-diabetic patients with left main and/ or three-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents by Banning AP et al.
    Marx N
    Diab Vasc Dis Res; 2011 Apr; 8(2):173. PubMed ID: 21562069
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-eluting stent implantation for the treatment of cardiac transplant vasculopathy: the jury is still out.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jun; 77(7):970-1. PubMed ID: 21598349
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes mellitus does not unsweeten left main intervention.
    Williams DO; Abbott JD
    JACC Cardiovasc Interv; 2009 Oct; 2(10):964-6. PubMed ID: 19850256
    [No Abstract]   [Full Text] [Related]  

  • 18. Stenting the coronaries and bypassing the evidence in patients with multivessel coronary artery disease: time to set the record straight.
    Zingone B
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):362-70. PubMed ID: 17443104
    [No Abstract]   [Full Text] [Related]  

  • 19. The fork in the road: a dedicated turn or a provisional one?
    Mehran R
    Catheter Cardiovasc Interv; 2011 May; 77(6):807-8. PubMed ID: 21520382
    [No Abstract]   [Full Text] [Related]  

  • 20. The Slauson cutoff and peri-operative risk for abdominal vascular surgery.
    Butman SM
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):142-3. PubMed ID: 21181974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.